David C. Miller, a distinguished urologist and expert in urological oncology, will take on the roles of executive vice president for medical affairs and CEO of Michigan Medicine at the University of Michigan. The Board of Regents approved the appointment on Sept. 19, effective July 1, 2025. Miller will succeed Marschall S. Runge, who has held these positions since 2015.
Miller is currently the executive vice dean of clinical affairs for the Medical School and president of U-M Health. He oversees strategic, operational, clinical, cultural, and financial performance for Michigan Medicine’s clinical enterprise, which includes nearly 2,000 physicians and 140 clinics at 40 sites. “Dr. Miller is an extraordinary leader, a brilliant researcher, and the kind of doctor we all hope for when we need exemplary care,” President Santa J. Ono said.
Runge, the first individual in U-M history to serve in all three medical leadership roles, will retire from leadership on June 30, 2025, but remain a faculty member. A search for a new Medical School dean will be announced later. Miller’s appointment follows an engagement process and a July stakeholder survey that gathered 2,000 responses about challenges and opportunities for U-M’s health and medical enterprises.
Miller expressed gratitude for the opportunity, saying, “I owe a debt of gratitude to Dr. Runge for his leadership, mentorship, and tireless work on behalf of our doctors, nurses, staff, students, and, most especially, our patients.” He emphasized his commitment to working collaboratively with colleagues to ensure the University of Michigan remains a top choice for patient care, education, and research.
Since 2021, Miller has led U-M Health through the COVID-19 pandemic, focusing on continuous improvement and teamwork. He implemented strategic priorities centered on belonging and inclusion, access, safety and quality, patient and team member experience, strategic growth, and financial sustainability. Miller has also overseen the integration of UM Health-Sparrow and UM Health-West, the expansion of ambulatory care services, and innovative clinical programs.
Before his current role, Miller was chief clinical officer for University Hospital and the Frankel Cardiovascular Center. He joined the U-M faculty in 2008 and is a professor of urology. Miller received his medical training at the Washington University School of Medicine and completed his residency in U-M’s urology department. His research training includes a Master of Public Health degree in epidemiology from U-M and health services research fellowships at U-M and UCLA/RAND Corp.
—
Read More Michigan News
